Association between Myeloperoxidase Levels and Risk of Insulin Resistance in Egyptian Obese Women
Open Access
- 6 April 2018
- journal article
- Published by Scientific Foundation Spiroski (publications) in Open Access Macedonian Journal of Medical Sciences
- Vol. 6 (4) , 629-633
Abstract
BACKGROUND: Myeloperoxidase (MPO) is an enzyme involved in the pathogenesis of several diseases.AIM: The current study aimed to investigate serum MPO levels in obese Egyptian women and assess its relation with insulin resistance (IR) and other biochemical risk parameters.METHODS: The study included 80 obese women and 50 age-and-sex-matched healthy controls. Insulin resistance (IR) was evaluated by the Homeostasis Model Assessment-Insulin Resistance (HOMA-IR). Serum MPO, fasting glucose, insulin and blood lipids and anthropometry were measured. Obese cases were divided into three groups based on MPO tertiles. ROC analysis was performed to obtain the optimal cut-off values of MPO to predicate IR in obese women.RESULTS: The mean serum MPO was significantly higher in obese cases than controls. Cases in the highest MPO tertile had higher HOMA-IR, blood lipids and pressure levels compared with those in the lower tertile. The cutoff point of MPO was > 87.8 (ng/mL) and area under curves was 0.82 (p < 0.01) for diagnosis of IR. MPO levels were higher in obese Egyptian women than healthy controls.CONCLUSION: Elevation of MPO was associated with abnormal metabolic parameters. MPO might be used as an earlier biomarker for IR and metabolic disturbance in obese women.Keywords
This publication has 28 references indexed in Scilit:
- Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional studyBMC Endocrine Disorders, 2013
- Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE studyExperimental & Molecular Medicine, 2013
- White Blood Cell Counts as Risk Markers of Developing Metabolic Syndrome and Its Components in the Predimed StudyPLOS ONE, 2013
- Prevalence, Predictors, and Impact of Low High-Density Lipoprotein Cholesterol on in-Hospital Outcomes Among Acute Coronary Syndrome Patients in the Middle EastThe Open Cardiovascular Medicine Journal, 2011
- Complications of obesity in children and adolescentsInternational Journal of Obesity, 2009
- Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy IndividualsJACC, 2007
- Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humansFree Radical Biology and Medicine, 2006
- Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in HumansCirculation, 2004
- Definition of Metabolic SyndromeCirculation, 2004
- Myeloperoxidase Functions as a Major Enzymatic Catalyst for Initiation of Lipid Peroxidation at Sites of InflammationJournal of Biological Chemistry, 2002